Anxiety Disorders Completed Phase 3 Trials for Fluvoxamine (DB00176)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000389Treatment for Anxiety in ChildrenTreatment